Lifeward Welcomes Dr. Keith E. Tansey
Lifeward, a global leader in rehabilitation technology, is adding a key voice to its Medical Affairs team. Dr. Keith E. Tansey, a widely respected specialist in spinal cord injury (SCI) medicine, will join as Consulting Director of Clinical Research. The appointment reflects Lifeward’s ongoing commitment to better care for people living with physical disabilities and to growing the real-world impact of its solutions.
Deep Expertise, Practiced Over Decades
Dr. Tansey brings more than 30 years of experience to the role. He currently serves as a Professor in the Department of Neurosurgery at the University of Mississippi Medical Center and is recognized as a Physician Scientist focusing on SCI. He is a board-certified Neurologist with additional certifications in spinal cord injury medicine and neural rehabilitation—credentials that speak to both the breadth and depth of his training.
A Career Built on Standards and Service
Throughout his career, Dr. Tansey has contributed to advisory boards and committees, including the International Society for Restorative Neurology and the American Society for Neurorehabilitation. He also played a key role in revising the International Standards for Neurological Classification of Spinal Cord Injury, work that helps guide consistent assessment and communication across the field.
What This Means for Lifeward
Larry Jasinski, CEO of Lifeward, shared his enthusiasm for Dr. Tansey’s appointment, noting his long-standing dedication to SCI care and research. Dr. Tansey’s experience aligns with Lifeward’s mission to broaden access to personal exoskeletons—technology designed to support people facing mobility limitations—while strengthening the clinical foundation behind their use.
Driving Clinical Research in Rehabilitation Technology
With flagship products such as the ReWalk Exoskeleton and the AlterG Anti-Gravity system, Lifeward has laid a strong technical base. Dr. Tansey will help advance that work by leading clinical research initiatives, shaping trials that evaluate meaningful outcomes, and exploring partnerships that can translate innovation into everyday rehabilitation practice. The goal is straightforward: better patient outcomes and more practical use of exoskeletons in care settings.
Lifeward’s Mission, In Practice
Lifeward designs and produces rehabilitation solutions that address real-world physical limitations. The company’s innovations emphasize function and health benefits, whether in clinical programs or at home. The aim is to help people reclaim independence—standing, walking, participating—and return to activities they value with support from proven technologies.
Global Footprint and Steady Growth
Founded in 2001, Lifeward operates in the United States, Israel, and Germany and continues to build on a diverse product portfolio. Offerings such as the MyoCycle FES System and the ReStore Exo-Suit reflect a focused pursuit: advancing tools that can elevate quality of life for people with physical disabilities, from early rehabilitation through everyday use.
Frequently Asked Questions
Who is Dr. Keith E. Tansey?
Dr. Keith E. Tansey is a Physician Scientist and board-certified Neurologist with more than 30 years of experience in spinal cord injury medicine. He serves as a Professor in the Department of Neurosurgery at the University of Mississippi Medical Center and has been appointed Consulting Director of Clinical Research at Lifeward.
What will Dr. Tansey do at Lifeward?
As Consulting Director of Clinical Research, he will guide Lifeward’s clinical research program—shaping trials, refining outcome measures, and pursuing partnerships—to support the use of personal exoskeletons and other rehabilitation technologies.
How does this appointment support Lifeward’s mission?
Dr. Tansey’s expertise directly supports Lifeward’s goal to expand access to personal exoskeletons and improve care for people with mobility limitations. His background strengthens the clinical evidence behind technologies designed to help individuals live more independently.
Which products are part of Lifeward’s portfolio?
Lifeward’s portfolio includes the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit, with solutions intended for both clinical and home use.
Where does Lifeward operate and when was it founded?
Lifeward was founded in 2001 and maintains operations in the United States, Israel, and Germany, supporting its mission to innovate in rehabilitation and mobility.
